Cancer Chemotherapy II

  • K. Hellmann
  • T. A. Connors

Part of the Chemotherapy book series (CT, volume 8)

Table of contents

  1. Front Matter
    Pages i-xviii
  2. L. S. Evseenko, S. W. Gorkova, E. A. Minenkova, M. M. Fomina, G. G. Poroshenko
    Pages 1-3
  3. J. de Ruiter, T. Smink, J. Jansen, L. M. van Putten
    Pages 9-10
  4. G. F. Rowland, G. J. O’Neill, D. A. L. Davies
    Pages 11-16
  5. I. Barasoain, A. Portoles, J. M. Rojo, C. Sunkel
    Pages 21-26
  6. E. Tsubura, K. Yata, G. Hisano, K. Tominaga, H. Sasaki, S. Sone
    Pages 27-30
  7. K. Lapis, A. Jeney, L. Kopper, B. Szende, J. Takacs
    Pages 37-42
  8. H. Fujita, M. Sugiyama, K. Kimura
    Pages 51-57
  9. Michiaki Kawano, Katsuhito Kohzai, Osamu Saitoh, Eiro Tsubura
    Pages 59-62
  10. A. De Barbieri
    Pages 87-89
  11. V. C. Barry, J. G. Belton, M. L. Conalty
    Pages 97-101
  12. V. C. Barry, M. L. Conalty, J. F. O’Sullivan, D. Twomey
    Pages 103-106
  13. M. De Brabander, R. Van de Veire, F. Aerts, G. Geuens, L. Desplenter, J. De Crée et al.
    Pages 121-128
  14. V. A. Shorin
    Pages 129-132
  15. S. M. Navashin, T. G. Terentjeva, E. V. Bobikov, L. I. Torbochkina, A. B. Sokolov, Y. O. Sazykin et al.
    Pages 133-138
  16. A. Jeney, É. Dzurillay, K. Lapis, L. Institoris
    Pages 145-151
  17. F. E. Knock, R. M. Galt, Y. T. Oester, R. Sylvester
    Pages 159-164
  18. Hamao Umezawa, Hideki Asakura, Makoto Hori
    Pages 165-168
  19. G. F. Gause, Y. V. Dudnik
    Pages 169-173
  20. T. Taniguchi, H. Niitani, A. Suzuki, N. Saijo, I. Kawase, K. Kimura
    Pages 175-183
  21. N. P. Pal’Mina, E. B. Burlakova, V. D. Gaintseva, N. P. Sezina
    Pages 185-190
  22. P. Chandra, T. J. Bardos, U. Ebener, B. Kornhuber, D. Gericke, A. Götz
    Pages 191-196
  23. L. B. Gorbacheva, G. V. Kukushkina, I. S. Sokolova, A. M. Serebryanyi, V. S. Tutlyte
    Pages 209-213
  24. J. L. Imbach, M. Hayat, E. Chenu, B. Serrou, G. Mathe
    Pages 221-228
  25. G. Mathé, M. Hayat, E. Chenu, I. Florentin, M. Bruley-Rosset, M. Janot et al.
    Pages 229-235
  26. G. Jolles, R. Maral, M. Messer, G. Ponsinet
    Pages 237-241
  27. Michiko Aoshima, Shigeru Tsukagoshi, Yoshio Sakurai, Jun-ichi Oh-ishi, Minoru Akiyama, Torao Ishida
    Pages 243-248
  28. D. Razis, M. Constantoulakis, M. Dimitriadis, A. Athanassiou, T. Messaropoulos
    Pages 249-255
  29. J. B. Healy
    Pages 257-264
  30. Kunihiro Funahashi, R. Esaki, J. Hayashi, T. Itoh, K. Shibata
    Pages 269-274
  31. Ch. Cerni, O. Kokron, M. Micksche, R. Titscher, H. Wrba
    Pages 287-293

About this book


The International Society of Chemotherapy meets every two years to review progress in chemotherapy of infections and of malignant disease. Each meeting gets larger to encompass the extension of chemotherapy into new areas. In some instances, exp~sion has been rapid, for example in cephalosporins, pen­ icillins and combination chemotherapy of cancer - in others slow, as in the field of parasitology. New problems of resistance and untoward effects arise; reduction of host toxicity without loss of antitumour activity by new substances occupies wide attention. The improved results with cancer chemotherapy, es­ pecially in leukaemias, are leading to a greater prevalence of severe infection in patients so treated, pharmacokinetics of drugs in normal and diseased subjects is rece1v1ng increasing attention along with related problems of bioavailability and interactions between drugs. Meanwhile the attack on some of the major bacterial infections, such as gonorrhoea and tubercu­ losis, which were among the first infections to feel the impact of chemotherapy, still continue to be major world problems and are now under attack with new agents and new methods. From this wide field and the 1,000 papers read at the Congress we have produced Proceedings which reflect the variety and vigour of research in this important field of medicine. It was not possible to include all of the papers presented at the Congress but we have attempted to include most aspects of cur­ rent progress in chemotherapy.


cancer chemotherapy kinetics pharmacokinetics research resistance toxicity

Editors and affiliations

  • K. Hellmann
    • 1
  • T. A. Connors
    • 2
  1. 1.Westminster Hospital and Imperial Cancer Research FundUK
  2. 2.Chester Beatty Research InstituteUK

Bibliographic information